Modulation of human cardiac function through 4 beta-adrenoceptor populations

Current understanding of beta-adrenoceptor function in the human heart remains incomplete. While beta 1-, beta 2-, and beta 3-adrenoceptors are well-characterized, a fourth receptor population has been proposed but not yet cloned. Prior research has shown that beta 1 and beta 2 receptors are primarily coupled to Gs proteins and influence systolic and diastolic function. However, the role of beta 3 and the putative beta 4-adrenoceptors in human cardiac physiology is less clear. No prior work had resolved how these receptor populations interact during normal and pathological conditions. This uncertainty drove the need for a comprehensive review of existing evidence. The gap in knowledge includes the mechanisms by which beta 3 and beta 4 receptors modulate cardiac function. Understanding these mechanisms could clarify how different adrenergic agonists and antagonists affect the heart. The review approach aims to synthesize findings from multiple studies to identify patterns and inconsistencies in receptor function.

The purpose of this review is to examine the role of four distinct beta-adrenoceptor populations in human cardiac function. The authors aim to clarify how these receptors modulate systolic and diastolic performance. The motivation stems from the need to understand the physiological and pharmacological implications of beta-adrenoceptor diversity. The review focuses on how beta 1-, beta 2-, beta 3-, and putative beta 4-adrenoceptors influence cardiac function. The authors also seek to highlight novel features of these receptors, such as their coupling to G proteins and their effects on ion channels. The review addresses whether unoccupied beta-adrenoceptors can modulate cardiac function. By analyzing existing literature, the authors aim to identify gaps in current knowledge. This synthesis may inform future studies on beta-adrenoceptor-targeted therapies.

The authors conducted a literature review to assess the evidence for four beta-adrenoceptor populations in the human heart. They analyzed studies that examined receptor coupling to G proteins and their effects on cardiac function. The review approach included comparing findings from human cardiac tissue and recombinant receptor systems. The authors evaluated evidence for the role of beta 1- and beta 2-adrenoceptors in modulating systolic and diastolic function. They also assessed the coupling of beta 3-adrenoceptors to Gi proteins and their effects on ion channels. The review approach included examining the effects of beta-adrenoceptor agonists and antagonists on cardiac function. The authors considered whether unoccupied receptors could influence cardiac performance. The synthesis of findings aimed to clarify the physiological roles of each receptor subtype.

Human cardiac beta 1- and beta 2-adrenoceptors are coupled to Gs proteins, with beta 2 receptors showing tighter coupling. Activation of these receptors increases systolic force and hastens diastolic relaxation through cyclic AMP-dependent phosphorylation of phospholamban and troponin 1. Beta 1 and beta 2 receptors can mediate arrhythmias in human cardiac preparations. Beta 3-adrenoceptors appear to be coupled to a pertussis toxin-sensitive Gi protein. Beta 3-selective agonists shorten the action potential and cause cardiodepression, suggesting direct coupling to a K+ channel. Putative beta 4-adrenoceptors mediate cardiostimulant effects of high-affinity beta 1- and beta 2-adrenoceptor blockers at high concentrations. These receptors are coupled to a cyclic AMP-dependent cascade and can undergo desensitisation. The evidence suggests that beta 4 receptors may play a role in non-conventional agonist effects.

The authors propose that four beta-adrenoceptor populations modulate human cardiac function. Beta 1 and beta 2 receptors influence systolic and diastolic performance through Gs protein coupling. Beta 3 receptors appear to be coupled to Gi proteins and may affect ion channels. Putative beta 4 receptors mediate effects of high-affinity blockers at high concentrations. The authors suggest that unoccupied beta 1 and beta 2 receptors may modulate cardiac function. The evidence supports the idea that beta-adrenoceptor diversity contributes to cardiac regulation. The review highlights gaps in understanding the physiological roles of beta 3 and beta 4 receptors. The authors propose that further research is needed to clarify the mechanisms of these receptors.